bioRxivCancer BiologyPreprint
A Rare Multipotent Peg-like Epithelial Cell is a Candidate Cell-of-Origin for High-Grade Serous Ovarian Cancer
Megan L. RittingiD, Wenmei Yang, Syed Mohammed Musheer AalamiD, Hui ZhaoiD, Feng LiangiD, Jianning Song, Mihai Gabriel DumbravaiD, Wazim Mohammed IsmailiD, Dong‐Gi MuniD, Chunling HuiD, Opalina Roy, Keyur Chaludiya, Geng Xian Shi, Daphne Norma CrastaiD, Kenneth Schaufelberger, Jeffrey R. JanusiD, Guruprasad KalthuriD, S. John WerohaiD, Scott H. KaufmanniD, Anguraj SadanandamiD, David J. H. F. KnappiD, Chen WangiD, Akhilesh PandeyiD, Alexandre Gaspar‐MaiaiD, Fergus J. CouchiD, , Nagarajan KannaniD
Abstract
To illuminate the origins of high-grade serous ovarian cancer (HGSOC), the most lethal and common form of ovarian cancer, we have created a comprehensive living organoid biobank of human fallopian tube tissue, which is thought to be the origin of this cancer. Through optimized culture protocols and integrated multi-omic profiling--including single-cell RNA sequencing, chromatin accessibility (ATAC) analysis, proteomics, and secretomics--we assembled the largest molecular atlas of the fallopian tube epithelium to date. This resource revealed diverse epithelial lineages and regulatory networks, including a rare, multipotent epithelial subpopulation with hybrid epithelial-mesenchymal features. Spatially localized to the basal epithelium and resembling mesonephric developmental precursors, these cells exhibit transcriptomic and proteomic similarities to the mesenchyme-like subtype of HGSOC, implicating them as potential cells-of-origin. Their molecular identity is preserved in organoid models, enabling future mechanistic and translational studies. This resource, which advances fundamental understanding of epithelial hierarchy and cancer susceptibility, provides a platform to inform early detection and prevention strategies for aggressive forms of ovarian cancer. HighlightsO_LIEstablishment of a clinically annotated fallopian tube organoid biobank enables delineation of epithelial lineage hierarchies and differentiation capacity. C_LIO_LIMulti-omics integration defines robust, lineage-specific transcriptional and regulatory networks in the fallopian tube epithelium. C_LIO_LIA rare basal epithelial subpopulation with mesenchymal features aligns with a mesenchyme-like subtype of high-grade serous ovarian cancer. C_LIO_LIRare basal peg cells exhibit fetal mesonephric developmental transcriptional programs and are maintained ex-vivo in fallopian tube organoids. C_LI
- organism: human
- assay: scRNA-seq
- assay: ATAC-seq
- assay: proteomics
- assay: metabolomics
- research focus: cell type annotation
- research focus: clustering
- research focus: gene regulatory network inference
- approach: deep learning
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrated Human Transcriptomics Identifies Fallopian Tube Progenitors as Plausible Precursors of High-Grade Serous Ovarian Cancer
Qian Li, Keren Cheng, … Wei Yan·bioRxiv·Sep 26, 2025
- Both Fallopian Tube and Ovarian Surface Epithelium Can Act as Cell-of-Origin for High Grade Serous Ovarian Carcinoma
B. G. Neel, S. Zhang, … D. A. Levine·bioRxiv·Nov 29, 2018
- Integrated Molecular Profiling Studies to Characterize the Cellular Origins of High-Grade Serous Ovarian Cancer
Kate Lawrenson, Marcos A.S. Fonseca, … Houtan Noushmehr·bioRxiv·May 25, 2018
- Rete Ovarii Epithelial Cells as an Unappreciated Cell of Origin for Pelvic and Ovarian High-Grade Serous Carcinoma
Cheng Wang, Peichao Chen, … John S. Davis·bioRxiv·Oct 31, 2025
- Single-cell Transcriptomics Identifies Gene Expression Networks Driving Differentiation and Tumorigenesis in the Human Fallopian Tube
Huy Q. Dinh, Xianzhi Lin, … Kate Lawrenson·Cell ReportsPeer-reviewed·Apr 1, 2021
- A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high grade serous ovarian cancer
P. Lo Riso, C. E. Villa, … G. Testa·bioRxiv·Nov 30, 2018